Sen. Klobuchar calls out Rising Pharma for price-gouging an old generic drug in shortage

Minnesota Democrat Sen. Amy Klobuchar sent a letter on Thursday to Rising Pharmaceuticals over the company’s decision to price its generic drug to treat lead poisoning at $32,000, which has led hospitals to no longer afford it or carry it.

While the FDA allowed Rising to bring this polyvalent ion chelator, known as edetate calcium disodium, to alleviate a shortage, Klobuchar notes that its price is “ten times the price of the imported version from France,” which is leading to access issues.

Preview

来源: EndPoints

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP

LOG IN

BECOME A PREMIUM SUBSCRIBER

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。